Additionally, the glycolysis inhibitor 3-BP (HK2 inhibitor) antagonized S100A9 overexpression, effects, suggesting that the regulation of glycolysis plays a critical role in the involvement of S100A9 in allergic asthma and HK2 might be a target of S100A9. Here, HK2 is linked to allergic asthma.